CLINICAL_TRIALS
trial_result
· 2024-05-29
Clinical Trial Update: Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain. [Phase 3]
Summary
A Phase 3 trial evaluating linzagolix for endometriosis-associated pain has completed, and its efficacy and safety results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-29